A full PDF version of the Masters' Award requirements is available here.

​

Competition Timeline: Submissions accepted from April 15, 2025 @ 16:00 (EDT) to  May 16th, 2025 @ 23:59 (EDT). An independent national review committee will review submissions. Results will be announced in early July 2025.

​

Duration: One (1) year. Applicants can resubmit to future award programs after 1 year.

​

Starting Date: Between September 1st, 2025 and before December 1st, 2025. If there are extenuating circumstances, the awardee can discuss with the award committee.

​

Funding Value: Successful applicants will receive a stipend up to CDN $15,000. The award will be issued to the applicant's academic institution. This studentship may be held in conjunction with other awards, provided the total combined funding does not exceed the maximum allowed by the institution, provincial co-funder, and the terms of any active awards held by the applicant. Please note that this award cannot be combined with an existing CIHR studentship. Any CIHR studentship—including those offered through affiliated organizations or initiatives (e.g., the Strategy for Patient-Oriented Research [SPOR])—will be considered a current CIHR award if it remains active at the proposed start date of the CAN-TAP-TALENT award. Provincial co-funder policies regarding co-funding or concurrent funding will also apply.

​

Eligibility

Full-time Masters students who are conducting research related to various types of clinical research, also including the analysis of clinical research samples and/or data, and which are aligned with the vision and mission of CAN-TAP-TALENT. At the time of funding, students must be enrolled (full-time) or accepted in a Canadian Masters degree program and must be a Canadian resident or permanent resident or hold a valid Canadian student visa.​

​

• Only one application per individual will be accepted

• Candidates are only permitted to apply to one CTTP out of the 4 namely, CANTRAIN, CAN-TAP-TALENT, StrokeCog or CBITN per year (response to an annual call for application will be considered for that year as the dates for the call may vary from year-to-year) while a Supervisor can submit as many candidates as desired to increase the probability of funding to his clinical trials operations.

• If candidates are unsure of their successful acceptance to the university program at the time of their application, they are asked to provide proof of acceptance once it is received. The award will be contingent on their successful acceptance to the program in the application.

  

The program considers scientific excellence and aims to support the full and fair participation of all members of the health research community through consideration of barriers experienced by underrepresented groups, with respect to equity, diversity and inclusion (EDI) principles.